Skip to main content

Advertisement

SpringerLink
Log in

Managing the Refractory Idiopathic Overactive Bladder with OnabotulinumtoxinA: Phase 2 Trial

  • Clinical Trial Report
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  1. Anger JT, Weinberg A, Suttorp MJ, et al. J Urol. 2010;183:2258–64.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, The Methodist Hospital, Methodist Neurological Institute, 6560 Fannin, Suite 2100, Houston, TX, 77030, USA

    Timothy B. Boone

Authors
  1. Timothy B. Boone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Timothy B. Boone.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boone, T.B. Managing the Refractory Idiopathic Overactive Bladder with OnabotulinumtoxinA: Phase 2 Trial. Curr Bladder Dysfunct Rep 6, 65–66 (2011). https://doi.org/10.1007/s11884-011-0082-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-011-0082-y

Keywords

Search

Navigation